SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- cardiovascular

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: sim15/1/2005 7:12:25 AM
   of 214
 
Heart Attack! An Unexpected Safety Risk
Examining COX-2 Inhibitors and Beyond
May 19-20, 2005

Hilton East Brunswick
East Brunswick, NJ

Event Description

Mission Statement:

Provide a high-level, interactive conference where participants acquire critical information regarding the incidence of cardiac ischemic events as it relates to the drug safety of COX-2 inhibitors and other relevant cardiac drug classes.

The reasons for the increased incidence of serious adverse events with COX-2 inhibitors are not fully understood by the medical community. The potential implications for sponsors, physicians and patients go far beyond this class of drugs. Additional research, testing and discussion will be necessary to move forward. Stay ahead of the curve with ExL Pharma's conference: Heart Attack! An Unexpected Safety Risk: Examining COX-2 Inhibitors and Beyond, the only drug safety conference of its kind directly related COX-2 inhibitors. We have assembled an expert speaking faculty to address some of the most controversial issues facing the pharmaceutical industry today.

* Alternative modalities for detecting cardiac ischemia
* Post-marketing nonrandomized studies
* CV risk among COX-2 inhibitors
* Cardiovascular endpoint studies
* Regulatory perspective on COX-2 inhibitors
* Technologies to be incorporated in studies of New Chemical and Biological Entities
* ECGs to determine CV safety

Join thought-leaders and your fellow industry colleagues at this landmark COX-2 conference.

Learn key information about the issues that everyone are reading and talking about!

exlpharma.com

Agenda
exlpharma.com
exlpharma.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext